UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C.  Form
10-KSB  ANNUAL
REPORT UNDER SECTION 13 OR 15(d) O THE SECURITIES EXCHANGE ACT OF 1934  For the
fiscal year ended December 31, 2007  Commission File No.
 333-141875  NURSE SOLUTIONS, INC. (Name of
small business issuer in its charter)  Nevada
20-5879021(State or other jurisdiction of incorporation or
organization)
(IRS Employer Identification No.)  439 West
Bockman Way Sparta,
TN 38583 (Address
of principal executive offices)  (913)
837-5344 (Issuers Telephone Number)  Securities registered
under Section 12(b) of the Exchange Act:  None  Securities registered
under Section 12(g) of the Exchange Act:  None  Check whether the
issuer is not required to file reports pursuant to Section 13 or 15(d) of the
Exchange Act.    [  ]  Check whether the
issuer (1) filed all reports required to be filed by Section 13 or 15(d) of the
Exchange Act during the past 12 months (or for such shorter period that the
registrant was required to file such reports), and (2) has been subject to such
filing requirements for the past 90 days.      Yes
 [X]    No  [  ]  Check if there is no
disclosure of delinquent filers in response to Item 405 of Regulation S-B
contained in this form, and no disclosure will be contained, to the best of
registrants knowledge, in definitive proxy or information statements
incorporated by reference in Part III of this Form 10-KSB or any amendment to
this Form 10-KSB.    [  ]   Indicate
by check mark whether the registrant is a shell company (as defined in Rule
12b-2 of the Exchange Act).  Yes  [  ]    No
 [X]  State
issuers revenues for its most recent fiscal year. $0.00  State the aggregate
market value of the voting and non-voting common equity held by non-affiliates
computed by reference to the price at which the common equity was sold, or the
average bid and asked price of such common equity, as of December 31, 2007.
 (See definition of affiliates in Rule 12b-2 of the Exchange Act.)
 $0.00  As of December 31,
2007, there were 17,094,000 shares of common stock issued and outstanding.  Transitional
Small Business Disclosure Format (Check one): Yes
[  ] No
[X]  PART
I  Item 1.
 Description of Business Business
Development Nurse
Solutions, Inc. (Nurse Soloutions) was incorporated in the State of Nevada on
November 14, 2006. Since its inception, Nurse Solutions has not been involved in
any bankruptcy, receivership or similar proceedings. It has not undergone any
material reclassification, merger, consolidation, or purchase or sale of a
significant amount of assets not in the ordinary course of business. Since
inception the Company has raised approximately $61,050.  The Company has
retained professional legal, transfer agent and accounting services.  It
has hired consultants to assist it in coordinating its regulatory filings and a
placement service working with hospitals, medical offices and doctors for the
placement of nurses. General Nurse
Solutions, Inc. intends to provide highly qualified registered nurses (RNs)
from around the globe to alleviate the alarming and growing shortage of RNs and
make it possible for healthcare organizations throughout the USA to hire skilled
nurses from abroad. We
will begin operations in the second quarter of 2008 by providing nurses for
clinics and hospitals through the USA and Canada, specifically to those
facilities involved with sleep disorder clinics.  The demand for registered
nurses far outweighs the supply and is projected to increase at a rapid rate.
 In 2000, 30 states were estimated to have shortages of 3% or more.
 By 2020, 44 states and the District of Columbia are projected to have
shortages.  At the same time, the number of new RN graduates fell,
resulting in 26% fewer RN graduates in 2000 than in 1995.  Due to declines
in enrollments, no graduate increase is expected in the short term.
 Associate degree graduates are declining with baccalaureate graduates
comprising a greater share of total   graduates.
 This has a constraining effect on supply growth due to
baccalaureate-prepared RNs, who need twice as long to complete their education
and enter the workforce.  The average age for RNs has climbed steadily,
resulting in a greater proportion of nurses approaching retirement age.
 The national supply of nurses in 2020 will be older but not larger than
the supply projected for 2005.  The number of new licenses in nursing is
projected to be 17% lower in 2020 than in 2002, while the loss from the RN
license pool due to death and retirement is projected to be 128% higher.
 RNs leave the license pool through death or retirement, at a faster rate
than ever before.  (Projected Supply, Demand, and Shortages of
Registered Nurses:  2000-2020, July 2002, U.S. Department of Health and
Human Services, Health Resources and Services Administration Bureau of Health
Professions National Center for Health Workforce Analysis.) Nurse
Solutions, Inc. plans to provide highly qualified registered nurses from around
the globe to alleviate the alarming and growing shortage of RNs and make it
possible for healthcare organizations through the USA and Canada to hire skilled
nurses from abroad. Marketing The
primary market includes doctors offices, clinics and hospitals conducting sleep
disorder clinics.  The secondary market includes additional hospitals and
health care clinics with nursing staff shortages.  The tertiary market
includes medically related facilities such as assisted care and home health
facilities.  Nurse Solutions intends to market its services through
existing relationships with doctors, facilities and service providers, as well
as through the mail and other direct advertisements. Hospital
and clinical executive management will receive a 6x9 two-sided, full color card
stock flyer, featuring the growing and alarming problem of nurse shortages and
the immediate solution presented by Nurse Solutions.  Nurse Solutions will
develop a website where potential clients can sign in, allowing Nurse Solutions
to better serve them and track potential business.  The website will
present them with statistical information on the growing shortages, screening
criteria and credentials of the potential candidates, testimonials from
satisfied clients, timeframes and general information. The
potential client can request a personalized solution to their shortage.  A
custom designed PowerPoint presentation outlining their personalized solution is
emailed to them and a copy is sent via US Mail.  A sales representative can
then follow up via telephone and email correspondence and present a formal
proposal for services. Pricing Based
on managements experience in the industry, prices for placement of a qualified
nurse, excluding transportation and government expenses which are paid by the
prospective employer, could range from $2,500 and $5,000. This fee will be paid
to Nurse Solutions by our prospective clients for the placement of each
qualified RN.  The fee will cover our costs and expenses associated in
locating, interviewing and placing an RN.   Competition As
the shortage of nurses grows, there is ample opportunity for providers of
qualified nurses and an increasing demand for the orchestration of the search
for nurses by an outside source.  Nurse Solutions specializes in full-time
placements, which is most desirable in the current economy. However,
medical facilities may already have contracted with an outside placement service
with a track record, such as the following · Soliant:
 Soliant Health has placements in 50 states, working with both large
metropolitan and small rural hospitals. · Nursefinders.
 Founded in 1974, today Nursefinders is located in 36 states with over 150
offices, with individuals working in a variety of disciplines. · InterimHealthcare.
 Founded in 1966, Interim HealthCare is the nations largest combined
provider of home care and supplemental health care staffing with nearly 300
locations throughout America. · Advanced
Med.  Advanced Med is a temporary staffing firm that provided
healthcare professionals to hospitals and clinics throughout the nation on a
contract and permanent basis. Nurse
Solutions is partnered with Sleep Associates Corporation, a private Nevada
corporation, in a position to offer services to that corporation.  There is
a ready supply of facilities needing assistance, due to the shortage forecasted
beyond 2007. Government
Regulation The
Company will be required to comply with the local rules and requirements of
doing business in each of the states where it places nursing staff.  The
Company is not aware of any other regulations which will affect its
business. Employees The
Company does not have any full time employees at this time. All management
activities are undertaken by the Company's Officer and Director. Insurance The
Company does not have insurance coverage at this time. Intellectual
Property None.   Item
2.  Description of Property Our
Primary address is located at 439 West Bockman Way, Sparta, TN 38583. Nurse
Solutions is supplied office space at this address by Steve Howell at no charge
to the Company during its development stage. Item
3.  Legal Proceedings Nurse
Solutions is currently not a party to any legal proceedings. Item
4.  Submission of Matters to a Vote of Security Holders No
matter was submitted during the fourth quarter of the fiscal year covered by
this report to a vote of security holders. PART II Item
5.  Market for Common Equity and Related Stockholder Matters and Small
Business Issuer Purchases of Equity Securities On
August 6, 2007, the Companys common stock was approved for trading on the
Over-the-county Bulletin Board under the symbol NRSS.  However, the stock
has not yet traded. As
of December 31, 2007, there were 41 shareholders of record. The
Company has not paid dividends on its stock, and does not have retained earnings
from which to pay dividends. Even if the Company was able to generate the
necessary earnings, it is not anticipated that dividends will be paid in the
foreseeable future, except to the extent required by the terms of any cumulative
preferred stock that may be authorized and issued in the future. Item
6.  Managements Discussion and Analysis or Plan of Operations The
following plan of operations should be read in conjunction with the December 31,
2007, audited financial statements and the related notes elsewhere in this
report. This discussion contains forward-looking statements based upon current
expectations that involve risks and uncertainties, such as our plans,
objectives, expectations and intentions. Our actual results and the timing of
certain events could differ materially from those anticipated in these
forward-looking statements. The business plan of
Nurse Solutions is to establish a market for the placement of qualified
registered nurses from abroad in medical offices and hospitals located within
the United States and Canada.  The Company will charge a fee ranging
between $2,500 and $5,000, excluding certain governmental expenses and
transportation which will be paid by the prospective client.   The
Companys business plan also includes the development of a website which will
allow prospective clients to learn about the Company and contact Nurse Solutions
for a presentation outlining a customized solution for their particular staffing
needs.  The Company has not
yet begun the development of its website.  However it currently has an
existing relationship with Sleep Associates Corporation, a private Nevada
corporation who deals with doctors and hospitals specializing in sleep
disorders.  Nurse Solutions will use this relationship to begin marketing
its services. The
funds available to the Company from private offerings were for a total of
$61,050 and are adequate for it to cover general and operating expenses and to
begin development of its website and marketing materials. The
Company does not have day-to-day operations and does not employ full or
part-time staff.  The Company pays fees for services to its attorney',
accountants, and transfer agent.  It retains additional services such as
technology, website design and assistance in procedures necessary to coordinate
the legal, accounting and regulatory filings from its consultants.  A fee
is paid for these services. The
Company will require additional cash, either from financing transactions or
operating activities, to meet our long-term goals. Our long-term goals will be
to develop our website and establish relationships with prospective clients. Over
the next twelve months, the Company intends to complete the following: 1. Hire
one employee and set up office, telephones, computers, website, marketing
materials, and infrastructure. 2. Set
up overseas placement company to coordinate complete placement of nurses. 3. Complete
all forms, standard operating procedures and any additional paperwork and
protocol needed to finalize placement and create written placement procedures
manual (overseas placement company to provide). 4. Sleep
Associates Corporation salespeople ask everyone they come in contact with if
they have a need for qualified nurses.  If so, they pass out the brochures
and they register the needs of the prospective customer with Nurse
Solutions. 5. Nurse
Solutions will capitalize on the free upfront marketing provided by Sleep
Associates Corporations salespeople and they will simply broker the nurses
using the overseas placement company to fulfill the needs of our
customers. 6. Commencing
in months 4 and 5, we will hire an additional employee and spend the money
necessary to go directly to the schools that train the nurses overseas so we can
by-pass the 50% placement commission paid to our overseas partner. The
Company estimates expenses over the next twelve months to complete the above
tasks to be $156,885.  The Company is expecting income from nurses placed
through existing relationships and referrals from Sleep Associates Corporation
to be approximately $168,700.   For
the year ended December 31, 2007, the Company has paid $16,538 in professional
fees for legal, and consulting fees for development of the Company, $9,500 for
accounting fees associated with audited financials; $20,000 in advertising
expenses and $74 in other general administrative expenses. Capital
and Liquidity As
of December 31, 2007, we had total current assets of $13,650, and no
liabilities, resulting in a working capital  of  $13,650. On
a long-term basis we do not have sufficient cash to meet our needs and we will
require additional cash, either from financing transactions or operating
activities, to meet our long-term goals over the next twelve months. The Company
will require additional financing over the next twelve months. There can be no
assurance that we will be able to obtain additional financing, either in the
form of debt or equity, or that, if such financing is obtained, it will be
sufficient for our needs or available to us on reasonable terms. In the event
that the Company is unable to obtain financing, the Company will seek joint
venture partners to assist in development with its technology and products. The
Company has had no discussions with potential merger candidates, and has no
knowledge of potential joint venture partners at this time.  If we are able
to obtain additional financing or structure strategic relationships in order to
fund existing or future projects, existing shareholders will likely experience
further dilution of their percentage ownership of the Company by the issuance of
additional shares to investors under terms not yet negotiated. The
Company has a net loss and deficit accumulated during this development stage of
$47,400. Item
7.  Financial Statements The
Companys audited financial statements for the year ended December 31, 2007 are
included herewith.        NURSE SOLUTIONS, INC.(A DEVELOPMENT STAGE COMPANY)BALANCE SHEETSDecember 31, 2007

December 31, 2006ASSETSCurrent AssetsCash
$
           11,150

$
            56,050Prepaid expenses
2,500

3,712Total current assets
13,650

59,762Total Assets
$
           13,650

$
            59,762LIABILITIES &
 STOCKHOLDERS' EQUITYTotal Liabilities
$
                   -

$
                    -Stockholders' EquityCapital stock:75,000,000 common shares authorized, $0.001 par
value;17,094,000 common shares issued
and outstanding atDecember 31, 2007 and December
31, 2006
17,094

17,094Additional paid-in capital
43,956

43,956Deficit accumulated during the development
stage
(47,400)

(1,288)Total Stockholders' Equity
13,650

59,762Total Liabilities & Stockholders'
Equity
$
           13,650

$
            59,762The accompanying notes are an integral part of
these financial statements.     NURSE SOLUTIONS, INC.(A DEVELOPMENT STAGE COMPANY)STATEMENTS OF OPERATIONSYear Ended December 31,
2007

Period of Inception (November 14,
2006) to December 31, 2006

Cumulative Totals from Inception
(November 14, 2006) to December 31, 2007REVENUES

$
                       -

$
                         -

$
                         -EXPENSESAdvertising expense
20,000

-

20,000Audit fees

9,500

-

9,500Professional fees
16,538

1,288

17,826Other general and administrative
74

-

74Total expenses
46,112

1,288

47,400NET LOSS APPLICABLE TO COMMON SHARES
$
              (46,112)

$
                  (1,288)

$
                (47,400)NET LOSS PER BASIC AND DILUTED SHARES
$
                (0.00)WEIGHTED AVERAGE NUMBER OF COMMON
SHARESOUTSTANDING

17,094,000The accompanying notes are an integral part of
these financial statements.


NURSE SOLUTIONS, INC(A DEVELOPMENT STAGE COMPANY)STATEMENT OF STOCKHOLDERS' EQUITYDeficitAccumulatedDuring the

TotalCommon Stock

Additional

Development

Stockholders'Shares

Amount

Paid-in-capital

Stage

EquityBalance on November 14, 2006
$
               -

$
           -

$
               -

$
                -

$
                -Common stock issued at $.001for cash - November 14,
2006
17,050,000

17,050

-

-

17,050Common stock issued at $1.00for cash - November 20,
2006
44,000

44

43,956

-

44,000Net loss
-

-

-

(1,288)

(1,288)Balance on December 31, 2006
17,094,000

17,094

43,956

(1,288)

59,762Net loss
-

-

-

(46,112)

(46,112)Balance on December 31, 2007
$  17,094,000

$    17,094

$
        43,956

$
      (47,400)

$
        13,650The accompanying notes are an integral part of
these financial statements.


NURSE SOLUTIONS, INC.(A DEVELOPMENT STAGE COMPANY)STATEMENTS OF CASH FLOWSYear Ended December 31, 2007

Period of Inception (November 14, 2006) to December 31,
2006

Cumulative totals from Inception (November 14, 2006) to
December 31, 2007CASH FLOWS
FROM OPERATING ACTIVITIESNet loss


$
         (46,112)

$
                    (1,288)

$
                  (47,400)Adjustments to
reconcile net loss to net cash provided by(used in)
operations:Decrease
(increase) in prepaid expenses
1,212

(3,712)

(2,500)Net cash used
in operating activities
(44,900)

(5,000)

(49,900)CASH FLOWS
FROM INVESTING ACTIVITIES
-

-

-CASH FLOWS
FROM FINANCING ACTIVITIESCommon stock
issued for cash
-

61,050

61,050Proceeds
received from notes payable - related parties
-

100

100Payments made on
notes payable - related parties
-

(100)

(100)Net cash
provided by financing activities
-

61,050

61,050NET INCREASE
(DECREASE) IN CASH AND CASHEQUIVALENTS

(44,900)

56,050

11,150Cash at
beginning of period
56,050

-

-Cash at end of
period

$
           11,150

$
                   56,050

$
                    11,150SUPPLEMENTAL
CASH FLOW INFORMATION:Cash paid for
interest

$
                   -

$
                           -

$
                           -Cash paid for
income taxes
$
                   -

$
                           -

$
                           -SCHEDULE OF
NON-CASH OPERATING, INVESTING,AND FINANCING
ACTIVITIES:NoneThe accompanying notes are an integral part of
these financial statements.


Nurse Solutions, Inc. (A Development Stage
Company) Notes to Audited
Financial Statements December 31, 2007 and
2006 NOTE 1. Organization and Summary of Significant Accounting
Policies This summary of significant accounting policies of Nurse
Solutions, Inc. (a development stage company) (the Company) is presented to
assist in understanding the Company's financial statements. These accounting
policies conform to accounting principles generally accepted in the United
States of America and have been consistently applied in the preparation of the
accompanying financial statements. The Company has not realized revenues from
its planned principal business purpose and is considered to be in its
development stage in accordance with SFAS 7, "Accounting and
Reporting by Development Stage Enterprises." Business
Activity The Company was
incorporated in Nevada on November 14, 2006 to provide highly qualified
registered nurses from around the globe to healthcare organizations throughout
the USA and Canada. The Company has elected a fiscal year end of December
31st.  Income Taxes The Company recognizes
the tax effects of transactions in the year in which such transactions enter
into the determination of net income, regardless of when reported for tax
purposes. Deferred taxes are normally provided in the financial statements under
SFAS No. 109 to give effect to the resulting temporary differences which may
arise from differences in the bases of fixed assets, depreciation methods,
allowances, and start-up costs based on the income taxes expected to be payable
in future years. Minimal development stage deferred tax assets of approximately
$16,600 arising as a result of net operating loss carryforwards have been offset
completely by a valuation allowance due to the uncertainty of their utilization
in future periods. Operating loss carryforwards generated during the period from
November 14, 2006 (date of inception) through December 31, 2007 of $47,400 will
begin to expire in 2025.  Foreign
Currency Transactions and
balances originally denominated in U.S. dollars are presented at their original
amounts. Transactions and balances in other currencies are converted into U.S.
dollars in accordance with Statement of Financial Accounting Standards (SFAS)
No. 52,"Foreign Currency Translation,"and are included in determining
net income or loss.  There were no net gains
and losses resulting from foreign exchange transactions that are included in the
statements of operations during the period presented.  Estimates Preparation of
financial statements in accordance with accounting principles generally accepted
in the United States of America requires management to make estimates and
assumptions that affect the reported amounts of assets and liabilities and
disclosure of contingent assets and liabilities at the date of the financial
statements and the reported amounts of revenues and expenses during the
reporting period. Actual results could differ from those estimates. The
Company's periodic filings with the Securities and Exchange Commission include,
where applicable, disclosures of estimates, assumptions, uncertainties and
markets that could affect the financial statements and future operations of the
Company.  Cash and Cash
Equivalents For the purpose of the
statements of cash flows, the Company considers all highly liquid debt
instruments purchased with a maturity of three months or less to be cash
equivalents. The Company had $11,150 and $56,050 in cash and cash equivalents at
December 31, 2007 and December 31, 2006, respectively.    Nurse Solutions, Inc. (A Development Stage
Company) Notes to Audited
Financial Statements (continued) December 31, 2007 and
2006  NOTE 1. Organization
and Summary of Significant Accounting Policies (continued)  Revenue
Recognition The Company's primary
revenue stream will be placement fees earned for the placement of qualified
nurses into various medical facilities. Revenue will be recognized once the
service is performed, persuasive evidence of an agreement exists, the price is
fixed or determinable and collectibility is reasonably expected.  Recently Issued
Accounting Pronouncements In December 2007, the
FASB issued SFAS No. 160, Noncontrolling Interests in Consolidated Financial
Statementsan amendment of ARB No. 51.This Statement amends ARB 51
to establish accounting and reporting standards for the noncontrolling interest
in a subsidiary and for the deconsolidation of a subsidiary. It clarifies that a
noncontrolling interest in a subsidiary is an ownership interest in the
consolidated entity that should be reported as equity in the consolidated
financial statements. This statement is effective as of the
beginning of an entitys first fiscal year that begins after December 15,
2008.  In February 2007,
the FASB issued SFAS No. 159, The Fair Value Option for Financial Assets and
Financial Liabilities  Including an amendment of FASB Statement No. 115.
 The fair value option established by this statement permits all entities
to choose to measure eligible items at fair value at specified election dates. A
business entity shall report unrealized gains and losses on items for which the
fair value option has been elected in earnings (or another performance indicator
if the business entity does not report earnings) at each subsequent reporting
date.  This statement is effective as of the beginning of an entitys first
fiscal year that begins after November 15, 2007.  In September 2006, the
FASB issued SFAS No. 157,Fair Value Measurements.This statement
defines fair value, establishes a framework for measuring fair value in
generally accepted accounting principles (GAAP), and expands disclosures about
fair value measurements.   This statement is effective for financial
statements issued for fiscal years beginning after November 15, 2007.  None of the above new
pronouncements has current application to the Company, but may be applicable to
the Companys future financial reporting.  NOTE 2. Net Income
or (Loss) Per Share of Common Stock The
Company has adopted Financial Accounting Standards Board ("FASB") Statement
Number 128, "Earnings per Share," ("EPS") which requires presentation of
basic and diluted EPS on the face of the statements of operations and
comprehensive loss for all entities with complex capital structures and requires
a reconciliation of the numerator and denominator of the basic EPS computation
to the numerator and denominator of the diluted EPS computation. In the
accompanying financial statements, basic earnings (loss) per share is computed
by dividing net income/loss by the weighted average number of shares of common
stock outstanding during the period.   Nurse Solutions, Inc. (A Development Stage
Company) Notes to Audited
Financial Statements (continued) December 31, 2007 and
2006  NOTE 2. Net Income
or (Loss) Per Share of Common Stock (continued)  The following table sets forth the
computation of basic and diluted earnings per share:  Year Ended
December 31,
2007

Period of
Inception (November 14, 2006) to December 31, 2006Net loss
$
(46,112)
$
(1,288)Weighted average common shares
outstanding (Basic)

17,094,000

17,055,617Options

-

-Warrants

-

-Weighted average common shares
outstanding (Diluted)

17,094,000

17,055,617Net loss per share (Basic and
Diluted)
$
(0.003)
$
(0.000)  The Company has no
potentially dilutive securities, such as options or warrants, currently issued
and outstanding.  NOTE
3.    Stockholders' Equity  Upon incorporation in
November 2006, the Company undertook a private offering of 17,050,000 shares of
its common stock, with an offering price of $0.001 per share for $17,050 in
cash. Also in November 2006, the Company issued 44,000 shares of its common
stock with an offering price of $1.00 per share for $44,000 in cash. The funds
raised from the two offerings totaled $61,050 and will be used to cover further
start-up and organizational costs of the Company. At December 31, 2007 and
December 31, 2006 the Company had 17,094,000 shares of common stock issued and
outstanding.  NOTE 4. Prepaid
Expenses  At December 31, 2007,
the Company had prepaid services in the amount of $2,500 to an unrelated
party.  NOTE 5. Going
Concern Considerations  The accompanying
financial statements have been prepared in conformity with accounting principles
generally accepted in the United States of America, which contemplate
continuation of the Company as a going concern. The Company is currently in the
development stage and has not generated revenues from its planned business
purpose. Realization of the assets of the Company is dependent upon the
Company's ability to meet its financial requirements through equity financing
and the success of future operations. These factors, among others, raise
substantial doubt about the Company's ability to continue as a going concern.
The accompanying financial statements do not include any adjustments that might
result from the outcome of this uncertainty.


Item
8.  Changes in and Disagreements with Accountants on Accounting and
Financial Disclosure  There have been no
changes in or disagreements with accountants over the past 2 years.  Item 8A.
 Controls and Procedures  The management of Nurse Solutions, Inc. is
responsible for establishing and maintaining adequate internal control over
financial reporting (as defined in Rule 13a-15(f) under the Exchange Act). Nurse
Solutions, Inc.s internal control system was designed to provide reasonable
assurance to the Companys management and Board of Directors regarding the
preparation and fair presentation of published financial statements in
accordance with U.S. generally accepted accounting principles. All internal
control systems, no matter how well designed, have inherent limitations.
Therefore, even those systems determined to be effective can provide only
reasonable assurance with respect to financial statement preparation and
presentation.  Management maintains a comprehensive system
of controls intended to ensure that transactions are executed in accordance with
managements authorization, assets are safeguarded, and financial records are
reliable. Management also takes steps to ensure that information and
communication flows are effective, and to monitor performance, including
performance of internal control procedures.  Nurse Solutions, Inc.s management assessed
the effectiveness of the Companys internal control over financial reporting as
of December 31, 2007 based on the criteria set forth by the Committee of
Sponsoring Organizations of the Treadway Commission (COSO) in Internal
Control-Integrated Framework. Based on this assessment, management believes
that, as of December 31, 2007, the Companys internal control over financial
reporting is effective.  Item 8B.
 Other Information  During the fourth
quarter of the fiscal year ended December 31, 2007, there was no information
required to be reported on Form 8K which was not previously reported.  PART
III  Item 9.
 Directors, Executive Officers, Promoters, Control Persons and Corporate
Governance; Compliance with Section 16(a) of the Exchange Act  Executive
Officers and Directors  Set
forth below is the name and age of each individual who was a director or
executive officer of Nurse Solutions as of December 31, 2007, together with all
positions and offices of the Company held by each and the term of office and the
period during which each has served: Name
Age
Position
with the Company
Term
Of OfficeTomasz
Zurawek
43
President/Director/CFO/Principal
Accounting Officer
From
Inception (November 14, 2006) to present    All
directors serve for a period of one year, or until the next annual shareholders
meeting. Biographical
Information The
following paragraphs set forth brief biographical information for the
aforementioned directors and executive officers: Mr. Tomasz Zurawek
graduated from the Medical Academy of Warsaw in 1987 with the degree of Medical
Doctor. He completed his postgraduate training at City Hospital Wola Wschod in
1989 and began an internal medicine and cardiology fellowship at the same
hospital. In 1991, Mr. Zurawek and his family immigrated to the United States
and after passing necessary exams he was accepted in spring of 1992 for internal
medicine residency followed by a pulmonary fellowship at Interfaith Medical
Center in Brooklyn, NY. He graduated from the program in 1997, being board
certified in internal medicine and later in pulmonary disorders.
 Eventually he was nominated as a fellow of the American College of Chest
Physicians. During five years of residency and fellowship Mr. Zurawek gained
extensive experience in pulmonary and sleep medicine and was author and coauthor
of several published articles pertaining to the area of multi-drug resistant
tuberculosis. In 1997 Mr. Zurawek with his family relocated to Centerville, TN
to fulfill his obligations in medically underserved area in order to become a
permanent resident in the United States. Mr. Zurawek served as a chief of staff
at Baptist Hickmann Community Hospital from 1997 until 2000, during that time he
furthered his education in sleep medicine along with performing his duties in
the emergency department as well as critical care and pulmonary consultant at
Baptist Hickmann Community Hospital. In 2000, Mr. Zurawek accepted the position
of the head of pulmonary division and ICU director at Horizon Medical Center in
Dickson, TN.  Mr. Zurawek
established his own pulmonary practice in 2003 in Dickson, TN and in the
following year he became board certified in sleep medicine and a Diplomat of the
American Board of Sleep Medicine. In 2006, Mr. Zurawek became board certified in
anti-aging medicine and a diplomat of American Academy of Anti-Aging
Medicine.  Mr. Tomasz Zurawek
was actively involved in recruitment of several foreign trained physicians and
over the years developed a strong interest in the process of nursing staff
placement. Mr. Zurawek has developed extensive contacts in medical and nursing
schools in his native Poland as well as in India.  Mr. Zurawek is actively
involved in patient care and maintains a successful medical office in Dickson,
as well as serving as an interpreting physician, medical director and consultant
in several hospitals and sleep labs across the state of Tennessee and Kentucky.
Mr. Zurawek has an unrestricted, active medical license in Tennessee and
Kentucky.  Involvement in
Certain Legal Proceedings  To our knowledge,
during the past five years, no present or former director or executive officer
of our company: (1) filed a petition under the federal bankruptcy laws or any
state insolvency law, nor had a receiver, fiscal agent or similar officer
appointed by a court for the business or present of such a person, or any
partnership in which he was a general partner at or within two   years
before the time of such filing, or any corporation or business association of
which he was an executive officer within two years before the time of such
filing; (2) was convicted in a criminal proceeding or named subject of a pending
criminal proceeding (excluding traffic violations and other minor offenses); (3)
was the subject of any order, judgment or decree, not subsequently reversed,
suspended or vacated, of any court of competent jurisdiction, permanently or
temporarily enjoining him from or otherwise limiting the following activities:
(i) acting as a futures commission merchant, introducing broker, commodity
trading advisor, commodity pool operator, floor broker, leverage transaction
merchant, associated person of any of the foregoing, or as an investment
advisor, underwriter, broker or dealer in securities, or as an affiliated
person, director of any investment company, or engaging in or continuing any
conduct or practice in connection with such activity; (ii) engaging in any type
of business practice; (iii) engaging in any activity in connection with the
purchase or sale of any security or commodity or in connection with any
violation of federal or state securities laws or federal commodity laws; (4) was
the subject of any order, judgment or decree, not subsequently reversed,
suspended or vacated, of any federal or state authority barring, suspending or
otherwise limiting for more than 60 days the right of such person to engage in
any activity described above under this Item, or to be associated with persons
engaged in any such activity; (5) was found by a court of competent jurisdiction
in a civil action or by the Securities and Exchange Commission to have violated
any federal or state securities law and the judgment was not subsequently
reversed, suspended or vacated; (6) was found by a court of competent
jurisdiction in a civil action or by the Commodity Futures Trading Commission to
have violated any federal commodities law, and the judgment in such civil action
or finding by the Commodity Futures Trading Commission has not been subsequently
reversed, suspended or vacated.  Code of
Ethics  The Company has not,
as of the date of this report, adopted a Code of Ethics.  Board of
Directors  Our
Board of Directors may designate from among its members an executive committee
and one or more other committees.  No such committees have been appointed
to date.  Accordingly, we do not have an audit committee or an audit
committee financial expert.  We are presently not required to have an audit
committee financial expert and do not believe we otherwise need one at this time
due to our lack of material business operations.  Similarly we do not have
a nominating committee or a committee performing similar functions.  Our
entire board serves the functions of an audit committee and a nominating
committee.  We have not implemented procedures by which our security
holders may recommend board nominees to us but expect to do so in the future,
when and if we engage in material business operations.  We are
not presently required to have independent directors.  Our current director
is not independent.  If we ever become a listed issuer whose securities are
listed on a national securities exchange or on an automated inter-dealer
quotation system of a national securities association, which has independent
director requirements, we intend to comply with all applicable requirements
relating to director independence.   Compliance with Section 16(a) of the Exchange
Act  Because
we do not have a class of equity securities registered pursuant to Section 12 of
the Exchange Act, our executive officers, directors and persons who beneficially
own more than 10% of our common stock are not required to file initial reports
of ownership and reports of changes in ownership with the SEC under Section
16(a) of the Exchange Act.  Item
10.  Executive Compensation  (a)
No officer or director of the Company is receiving any remuneration at this
time. (b) There are no
annuity, pension or retirement benefits proposed to be paid to officers,
directors, or employees of the corporation in the event of retirement at normal
retirement date pursuant to any presently existing plan provided or contributed
to by the corporation or any of its subsidiaries.  (c) No remuneration
is proposed to be paid in the future directly or indirectly by the corporation
to any officer or director under any plan which presently exists. There are no
plans to increase the number of employees significantly over the next twelve
months. Director
Compensation The
Directors of the Company do not receive compensation at this time, but are paid
consulting fees for specific services as incurred. Item
11.  Security Ownership of Certain Beneficial Owners and Management and
Related Stockholder Matters The
following table sets forth the beneficial ownership of the Company's officers,
directors, and persons who own more than five percent of the Company's common
stock as of the date of this filing. Under relevant provisions of the Exchange
Act, a person is deemed to be a "beneficial owner" of a security if he or she
has or shares the power to vote or direct the voting of the security or the
power to dispose or direct the disposition of the security. A person is also
deemed to be a beneficial owner of any securities of which that person has the
right to acquire beneficial ownership in 60 days. More than one person may be
deemed to be a beneficial owner of the same securities. The percentage ownership
of each stockholder is calculated based on the total number of outstanding
shares of our common stock of 17,094,000 as of the date of this filing. The
table is based upon information provided by our directors and executive
officers. Amount
and nature of beneficial ownership as of the date of this filing:    Name of
Beneficial Owner of Common Shares
Address of
Beneficial Owner
of common
Shares
Number of
Common
Shares
Owned
Percentage of
Issued and Outstanding Common SharesTomasz
Zurawek(1)

6,044,000
35.4% (1)Mr. Zurawek is the President and CFO, as well as the sole director. Item
12.  Certain Relationships and Related Transactions, and Director
Independence Other
than as set forth in this item, there are no relationships, transactions, or
proposed transactions to which the registrant was or is to be a party, in which
any of the named persons set forth in Item 404 of Regulation SB had or is to
have a direct or indirect material interest. Mr.
Zurawek, our sole director, is not independent under the independence standards
under Item 407(a)(1) of Regulation S-B. Item 13.
  EXHIBITS.  Exhibits  The
following Exhibits are being filed with this report on Form 10-KSB: Exhibit No.
SEC Report Reference Number
Description31.1

Rule
13(a)  14(a)/15(d)  14(a) Certification of Principal Executive and
Financial Officer.32.1

Rule
1350 Certification of Chief Executive and Financial Officer.


ITEM
14.  PRINCIPAL ACCOUNTANT FEES AND SERVICES.  Audit Fees The aggregate fees billed by our principal accountant for services
rendered during the fiscal years ended December 31, 2007 and December 31, 2006,
respectively, are set forth in the table below:  Fee Category
Year ended
December 31, 2007
Year ended December 31, 2006Audit fees
(1)
$
9,500
$
    0Audit-related
fees (2)
0
0Tax fees
(3)
0
0All other
fees (4)
0
0Total
fees
$
9,500
$
    0  (1) Audit fees consists of fees incurred for professional services
rendered for the audit of annual financial statements, for reviews of interim
financial statements included in our quarterly reports on Form 10-QSB and for
services that are normally provided in connection with statutory and regulatory
filings or engagements. (2) Audit-related fees consists of fees billed for professional
services that are reasonably related to the performance of the audit or review
of our financial statements, but are not reported under Audit fees. (3) Tax fees consists of fees billed for professional services
relating to tax compliance, tax advice and tax planning, consisting of
preparation of our corporate tax returns for the period ended December 31, 2007.
 Our principal accountants are currently preparing the 2007 tax return.  (4) All other fees consists of fees billed for all other
services.   Audit Committees Pre-Approval Policies and Procedures  We do not at this
time have an audit committee, therefore, no policies or procedures other than
those required by SEC rules on auditor independence, have been implemented.
 The Board of Directors will have to pre-approve the engagement of our
principal independent accountants to provide non-audit services.  Non-audit
services, consisting of the preparation of corporate tax returns by our
principal independent accountants in 2007 and 2006, were not pre-approved
pursuant to paragraph I(7)(i)I of Rule 2-01 of Regulation S-X.  Section
10A(i) of the Securities Exchange Act of 1934 prohibits our auditors from
performing audit services for us as well as any services not considered to be
audit services unless such services are pre-approved by the Board of Directors
(in lieu of an audit committee) or unless the services meet certain de minimis
standards.   SIGNATURES In
accordance with Section 13 or 15(d) of the Exchange Act, the registrant caused
this report to be signed on its behalf by the undersigned, thereunto duly
authorized. NURSE
SOLUTIONS, INC.  /s/
Tomasz Zurawek Tomasz
Zurawek, President   March
21, 2008 Date  In
accordance with the Exchange Act, this report has been signed below by the
following persons on behalf of the registrant and in the capacities and on the
dates indicated.  /s/
Tomasz Zurawek Tomasz
Zurawek, President, CFO, Principal Accounting Officer, Director   March
21, 2008 Date